PolicyBrief
H.R. 6005
119th CongressNov 10th 2025
Molly R. Loomis Research for Descendants of Toxic Exposed Veterans Act of 2025
IN COMMITTEE

This bill establishes research requirements and directs studies focused on the health conditions affecting the descendants of veterans exposed to toxic substances during military service.

Debbie Dingell
D

Debbie Dingell

Representative

MI-6

LEGISLATION

New VA Research Mandate Targets Birth Defects in Descendants of Toxic-Exposed Veterans, Starting with Agent Orange Study

This bill, officially titled the Molly R. Loomis Research for Descendants of Toxic Exposed Veterans Act of 2025, mandates a significant expansion of federal research into the health of veterans’ children and grandchildren. Simply put, it recognizes that toxic exposure during military service might not just affect the veteran, but also their biological descendants. The core of the bill is setting up the machinery to diagnose, treat, and ultimately understand the conditions passed down through generations.

Finally Looking at the Next Generation

For years, the focus has been on the veterans themselves—and rightly so. But this bill shifts the lens to the kids and grandkids. It amends the existing Sergeant First Class Heath Robinson Honoring our Promise to Address Comprehensive Toxics Act (PACT Act) to formalize this research. It requires the existing Interagency Working Group on Toxic Exposure Research to set up new task forces dedicated specifically to studying how to diagnose and treat health conditions in these descendants. This isn’t just about collecting data; it’s about finding practical solutions for conditions that might be linked to a parent's or grandparent's service. Think of it as a dedicated federal R&D department for generational health issues stemming from military service.

The Agent Orange Deep Dive

One of the most concrete provisions is a required study focused specifically on the biological descendants of veterans who served in Operation Ranch Hand. This was the group responsible for spraying Agent Orange during the Vietnam War. The Department of Veterans Affairs (VA) must now conduct a comprehensive study assessing the rates of birth defects and developmental delays in this population. For a veteran who has worried about their child’s health issues potentially being linked to their service, this is a crucial step toward getting answers. The VA will use existing biological samples and health records, but also conduct new surveys and genomic sequencing to find correlations and genetic markers. Crucially, the bill specifies that participation in this study is completely voluntary.

Transparency and the Public Website

To keep things above board, the bill mandates that the Working Group and the Agency for Toxic Substances and Disease Registry (ATSDR) maintain a public website. This site must detail their activities and findings, including a review of the data to determine the strength of evidence linking a descendant’s health condition to a veteran’s toxic exposure. This means that the public—and affected families—should have a clear window into what the government knows and how strong the scientific link is. It’s a good move for accountability, ensuring the findings don't just sit in a government report somewhere. The Working Group must also submit an initial report within one year and annual progress reports for five years, outlining their research findings and strategic plans, which means continuous oversight on this new effort.